Even before the worldwide pandemic, inevitable developments in our field were approaching, presenting both threats and opportunities. This article identifies six of the major developments and highlights the opportunities that could be nurtured for both patients and audiology practices.
Read More
In a new study published in the journal “Development,” USC Stem Cell scientists describe how adult flies can regenerate sensory hearing cells in their antennae, and how studying flies can provide a new way to understand and develop treatments for the hundreds of millions of patients worldwide who live with hearing and balance disorders.
Read More
Creighton University’s Translational Hearing Center has been awarded “the largest National Institutes of Health (NIH) grant in the university’s history,” according to an announcement from the Nebraska-based school.
Read More
New research announced by the Hearing Industries Association (HIA) reveals that 4 out of 5 Americans consider hearing loss serious, but ignoring the problem is more common than you may think. Fewer than 16% of adults ages 20-69 who need a hearing aid use one. That number almost doubles to 30% for adults over age 70 who need a hearing aid but don’t use one, according to the National Institute on Deafness and Other Communication Disorders (NIDCD).
Read More
Heuser Hearing Institute, a Louisville nonprofit, announced that Dr Ingrid Edwards has been chosen as a 2021 Health Care Hero from Louisville Business First. These annual awards recognize professionals who have made an impact on healthcare in their community through their concern for patients, research and inventions, management skills, innovative programs for employees, and service to the poor and uninsured.
Read More
Cooling the sensitive tissues of the inner ear before and during a cochlear implant surgery may lead to better hearing outcomes, according to a University of Miami Health System and College of Engineering researcher who is leading a collaborative team developing this therapeutic approach.
Read More
In experiments in newborn mice, scientists at Johns Hopkins report that sounds appear to change “wiring” patterns in areas of the brain that process sound earlier then scientists assumed and even before the ear canal opens.
Read More
Johns Hopkins Medicine researchers have shown that they can facilitate walking, relieve dizziness and improve quality of life in patients with BVH by surgically implanting a stimulator that electrically bypasses malfunctioning areas of the inner ear and partially restores the sensation of balance.
Read More
Primary progressive aphasia is a rare neurodegenerative condition characterized by prominent language problems that worsen over time. About 40% of people with the condition have underlying Alzheimer’s disease. But a new study has found that people with the condition may not develop the memory problems associated with Alzheimer’s disease.
Read More
Is there solid scientific evidence that hearing aids can fend off cognitive decline? Researcher Samira Anderson, AuD, PhD, explains results from some of the most compelling studies on this topic—including those she has been involved with—and provides insights into this exciting area of hearing healthcare science.
Read More
Research into how the brain and a person’s cognitive status is impacted by auditory input, speech, and social engagement continues at a fast pace. In this article, Douglas Beck and Michael Harvey summarize many of the most important and recent articles examining the relationships between cognition, audition, and amplification.
Read More
The findings are significant because no such FDA-approved drug currently exists, and the drug that has shown effectiveness to protect hearing in animal models in the study, dabrafenib, is an FDA-approved drug that is currently used in treating cancers.
Read More
A new study from Tel Aviv University (TAU) presents an innovative treatment for deafness, based on the delivery of genetic material into the cells of the inner ear. The genetic material “replaces” the genetic defect and enables the cells to continue functioning normally.
Read More
Gentamicin is used in US hospitals to treat a variety of bacterial infections, including infections in newborns and in other susceptible patients, such as those with cystic fibrosis. Yet researchers estimate that up to 20% of patients who are treated with it experience some degree of irreversible hearing loss.
Read More
Diabetes is a risk factor for Alzheimer’s disease (AD) and related dementias. More recently, hearing loss has also been linked to increased risk for AD.
Read More